Senior insider sale
Chief Science Officer at NOVOCURE LTD — senior position signals high conviction
$232.2K
17.14K shares
What this filing means
WEINBERG URI plans to sell 17.14K shares of NOVOCURE LTD valued at approximately $232.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/4/2026ACC: 0001950047-26-002217
Officer· Chief Science Officer
Since Apr 2020
17.14K
Shares to sell
$232.2K
Approx. market value
6.41K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted stock
Not Applicable
3/4/2026
6.41KTotal acquired6.41K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/4/2026 | Restricted stock Not Applicable | 6.41K | — |
| Total | 6.41K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
3.27K
Market value
$43.6K
3/2/2026
—Completed
Units to sell
7.46K
Market value
$103.3K
2/27/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
6.41K
Market value
$85.3K
3/4/2026
Total
Units
17.14K
Value
$232.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/2/2026 | 3.27K | $43.6K | — | Completed |
2/27/2026 | 7.46K | $103.3K | — | Completed |
| Planned — Approximate Date | ||||
3/4/2026 | 6.41K | $85.3K | NASDAQ | Planned |
| Total | 17.14K | $232.2K | ||